6.58
0.17 (2.65%)
| Penutupan Terdahulu | 6.41 |
| Buka | 6.24 |
| Jumlah Dagangan | 17,171 |
| Purata Dagangan (3B) | 15,605 |
| Modal Pasaran | 53,180,612 |
| Harga / Pendapatan (P/E TTM) | 131.60 |
| Harga / Jualan (P/S) | 1.69 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 14 Apr 2025 - 18 Apr 2025 |
| Hasil Dividen (DY TTM) | 7.60% |
| Margin Keuntungan | 1.26% |
| Margin Operasi (TTM) | -1.54% |
| EPS Cair (TTM) | 0.050 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 1.90% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 54.50% |
| Nisbah Semasa (MRQ) | 0.580 |
| Aliran Tunai Operasi (OCF TTM) | 6.01 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -3.05 M |
| Pulangan Atas Aset (ROA TTM) | 3.76% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Care Facilities (US) | Bercampur | Bercampur |
| Medical Care Facilities (Global) | Bercampur | Bercampur | |
| Stok | Cryo-Cell International, Inc. | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -1.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | -0.38 |
|
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida. |
|
| Sektor | Healthcare |
| Industri | Medical Care Facilities |
| % Dimiliki oleh Orang Dalam | 47.59% |
| % Dimiliki oleh Institusi | 12.76% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Sfi Advisors, Llc | 30 Sep 2024 | 165,300 |
| Massmutual Private Wealth & Trust, Fsb | 31 Dec 2024 | 111,035 |
| Rowlandmiller & Partners.Adv | 30 Sep 2024 | 0 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 08 May 2025 | Pengumuman | Cord Blood Banking Leader Cryo-Cell Announces Cash Dividend |
| 15 Apr 2025 | Pengumuman | Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2025 Financial Results |
| 28 Feb 2025 | Pengumuman | Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2024 |
| Hasil Dividen (DY TTM) | 7.60% |
| Purata Hasil Dividen 3T | 8.22% |
| Nisbah Pembayaran | 500.00% |
| Jangkaan Pembayaran Dividen Seterusnya | Nov 2025 |
| Tarikh EX | Tarikh Pengumuman | Tarikh Pembayaran | Perincian |
|---|---|---|---|
| 14 Feb 2025 | 29 Jan 2025 | 28 Feb 2025 | 0.25 Tunai |
| 15 Nov 2024 | 30 Oct 2024 | 29 Nov 2024 | 0.25 Tunai |
| 01 Sep 2022 | 19 Aug 2022 | 09 Sep 2022 | 0.9 Tunai |
Hasil Dividen Tahunan
| Tahun | Dividen Tahunan ($) | Kekerapan/Tahun | Hasil % |
|---|---|---|---|
| 2025 | 0.250 | 1 | 3.80 |
| 2024 | 0.250 | 1 | 3.37 |
| 2022 | 0.900 | 1 | 21.28 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |